Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00059189 · ClinicalTrials.gov registry record
Brain Plasticity of Verbal Memory in the Blind
A clinical trial of Blindness, sponsored by National Institute of Neurological Disorders and Stroke (NINDS).
- Completed
- Registry status
- 85
- Enrollment target
- 1
- Study location
NCT00059189 is a study of Blindness that has completed, run by National Institute of Neurological Disorders and Stroke (NINDS). The registered enrollment target is 85 participants, above the 47-participant average among 7 other Blindness trials with a reported enrollment target (81% higher). The trial reports 1 study location across 1 state.
The verdict
NCT00059189, a study of Blindness, has completed, sponsored by National Institute of Neurological Disorders and Stroke (NINDS).
- COMPLETED
- Registry status
- 85 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will examine whether blind people develop changes in the brain that improve memory function. Previous studies have shown that blind people, on average, perform better in memory tasks than sighted people. A possible reason for this is that parts of the brain that process visual information in sighted individuals are engaged in processing mnemonic (remembering) information in blind people. Blind and sighted people 18 years of age and older are eligible for this study. Healthy, sighted individuals may participate in Part 1 of the study, which is designed to find appropriate words to use in tests for Part 2 of the study. Part 2 will include sighted people and blind people. It will examine whether the (visual) brain in blind people is processing mnemonic information in a way that helps with day-to-day memory functions. Blind participants in this study must have lost their sight by age 4. Candidates will be screened with a medical interview and examination and a brief test of short-term and long-term verbal memory. Sighted patients will also be tested for visual memory and for handedness. Part 1 - Word Recognition Testing (2 sessions) * Session 1: Participants listen to a number of words over a loudspeaker and try to remember them for a memory test that will be given 30 minutes later. For the test, subjects listen to words again and press one of three buttons as quickly as possible after hearing the word. The buttons signal whether the subject does or does not recognize the word with a 1) high level of confidence or 2) low level of confidence. * Session 2: Participants hear a noun over a loudspeaker and have to find an appropriate verb for it, such as the verb (read) for the noun (book). Part 2 - MRI Scanning and TMS Experiments (5 - 7 sessions) * Magnetic resonance imaging (MRI): Participants perform the same procedures as described above for Part 1 while undergoing MRI of the brain. For this test, the subject lies on a table inside the MRI scanner - a na
Conditions Studied
Interventions
- DEVICE Magstim Rapid Magnetic Stimulator
Study Locations (1)
Maryland
- National Institute of Neurological Disorders and Stroke (NINDS) - Bethesda
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 85 participants |
| Start Date | 2003-04 |
| Est. Completion | 2005-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00059189
The ClinicalTrials.gov registry entry for NCT00059189 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 85 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 47-participant average among 7 other Blindness trials with a reported enrollment target (81% higher). The listed sponsor is National Institute of Neurological Disorders and Stroke (NINDS), which has 567 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Blindness appearing as the primary indexed condition, and to 1 intervention - of which Magstim Rapid Magnetic Stimulator is the first listed.
NCT00059189 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.
Frequently Asked Questions
What is clinical trial NCT00059189 about?
NCT00059189 is a clinical study titled "Brain Plasticity of Verbal Memory in the Blind". This study will examine whether blind people develop changes in the brain that improve memory function. Previous studies have shown that blind people, on average, perform better in memory tasks than sighted people. A possible reason for this is that parts of the brain that process visual information...
What is the current status of trial NCT00059189?
This trial is currently completed. The enrollment target is 85 participants. The study started on 2003-04. Estimated completion is 2005-04.
What conditions does trial NCT00059189 study?
This clinical trial studies the following conditions: Blindness.
What interventions are being tested in trial NCT00059189?
The interventions under investigation include: Magstim Rapid Magnetic Stimulator (DEVICE).
Who is sponsoring clinical trial NCT00059189?
This trial is sponsored by National Institute of Neurological Disorders and Stroke (NINDS), which has 567 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00059189 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Blindness
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Study to Evaluate Sepofarsen in Subjects With Leber Congenital Amaurosis (LCA) Type 10 (HYPERION)
RECRUITING · Phase 3
-
Testing Tactile Aids With Blind Subjects
RECRUITING · NA
-
A Study to Evaluate Efficacy, Safety, Tolerability and Exposure After a Repeat-dose of Sepofarsen (QR-110) in LCA10 (ILLUMINATE)
ACTIVE NOT RECRUITING · Phase 2
-
Enhanced Tactile Memory in the Blind
COMPLETED
-
A Study to Evaluate the BrainPort® Vision Device in Subjects Who Are Blind
COMPLETED · NA
-
Natural History Study of CEP290-Related Retinal Degeneration
COMPLETED
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.